Orgenesis Inc. Stock
Stocks
ORGS
US68619K3032
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
Market Closed -
OTC Markets
21:31:51 27/05/2026 HKT
|
5-day change | 1st Jan Change | ||
| 0.4500 USD | +181.25% |
|
+28.57% | +200.00% |
| 03-27 | Orgenesis Inc. Reports Earnings Results for the Full Year Ended December 31, 2024 | CI |
| 03-26 | Orgenesis Inc. Auditor Raises 'Going Concern' Doubt | CI |
| Market Cap | 985K 876K 812K 739K 1.39M 93.5M 1.42M 9.76M 3.83M 48.79M 3.7M 3.62M 156M | P/E 2023 |
-0.26x | P/E 2024 | -0.17x |
|---|---|---|---|---|---|
| Enterprise Value | 19.17M 17.04M 15.79M 14.37M 27.11M 1.82B 27.55M 190M 74.42M 949M 71.93M 70.4M 3.03B | EV / Sales 2023 |
71.2x | EV / Sales 2024 | 27x |
| Free-Float |
52.06% | Yield 2023 * |
-
| Yield 2024 | - |
| 1 day | +181.25% | ||
| 1 week | +28.57% | ||
| Current month | -18.18% | ||
| 1 month | -23.73% | ||
| 3 months | +44,900.00% | ||
| 6 months | +181.25% | ||
| Current year | +200.00% |
| 1 week | 0 |  | 0.45 |
| 1 month | 0 | | 0.67 |
| Current year | 0 | | 0.84 |
| 1 year | 0 | | 0.91 |
| 3 years | 0 | | 10.8 |
| 5 years | 0 | | 52 |
| 10 years | 0 | | 168 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sarah Ferber
CTO | Chief Tech/Sci/R&D Officer | 72 | 02/02/2012 |
Vered Caplan
CEO | Chief Executive Officer | 57 | 24/12/2013 |
Douglas Karriker
DFI | Director of Finance/CFO | 51 | 10/03/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Vered Caplan
CHM | Chairman | 57 | 14/08/2014 |
Itzhak Vider
BRD | Director/Board Member | 64 | 08/07/2024 |
Adam Pelavin
BRD | Director/Board Member | 47 | 28/10/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 5/3/25 | Other | 1,200,000 | 23.2142% | |||
| 12/12/24 | Free | Director | 1,500 | 0.0290% | ||
| 12/12/24 | Free | Director | 1,835 | 0.0355% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +181.25% | +28.57% | -55.00% | -94.79% | 556K | |
| +0.20% | +5.31% | -17.82% | +13.79% | 181B | |
| -0.73% | +7.09% | -0.31% | +32.06% | 116B | |
| +0.49% | +6.25% | -20.20% | +11.58% | 113B | |
| +3.83% | +5.50% | -44.18% | -6.77% | 79.83B | |
| -0.14% | +5.27% | +6.74% | +82.45% | 65.06B | |
| +2.79% | +2.37% | +15.93% | +68.64% | 54.35B | |
| -1.04% | +4.35% | +3.50% | -26.18% | 52.23B | |
| +2.41% | +8.18% | -12.08% | +30.45% | 44.15B | |
| -1.90% | +2.29% | +29.72% | +8.98% | 32.47B | |
| Average | +18.80% | +4.76% | -9.37% | +12.02% | 73.86B | |
| Weighted average by Cap. | +0.62% | +5.59% | -9.70% | +22.14% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 530K 471K 437K 397K 750K 50.3M 762K 5.25M 2.06M 26.25M 1.99M 1.95M 83.68M | 1.03M 920K 853K 776K 1.46M 98.23M 1.49M 10.25M 4.02M 51.26M 3.88M 3.8M 163M |
| Net income | -55.36M -49.21M -45.61M -41.5M -78.31M -5.25B -79.56M -548M -215M -2.74B -208M -203M -8.74B | -48.16M -42.81M -39.68M -36.1M -68.13M -4.57B -69.22M -477M -187M -2.39B -181M -177M -7.6B |
| Net Debt | 21.78M 19.36M 17.95M 16.33M 30.81M 2.07B 31.31M 216M 84.59M 1.08B 81.76M 80.01M 3.44B | 18.18M 16.16M 14.98M 13.63M 25.72M 1.73B 26.13M 180M 70.6M 900M 68.23M 66.78M 2.87B |
Employees
77
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/10/26 | US$0.0567 | +14,075.00% | 2,524 |
| 14/10/26 | US$0.000400 | -99.43% | 778 |
- Stock Market
- Stocks
- ORGS Stock
Select your edition
All financial news and data tailored to specific country editions
